Showing results (301-310 of 388) with videos related to

Sort By:
Pageof 39
Journal of Palliative Medicine|December 9, 2022
Establishing a Longitudinal Opioid Pharmacogenomic Registry for Cancer Patients: Feasibility and AcceptabilityJennifer Philip, Aaron Wong, Leeanne Pasanen, et al.
Brain, Behavior, and Immunity|February 8, 2022
Toll-like receptors change morphine-induced antinociception, tolerance and dependence: Studies using male and female TLR and signalling gene KO miceJacob H L Thomas, Liang Lui, Andrew Abell, et al.
British Journal of Clinical Pharmacology|May 4, 2006
An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazidThomas M Polasek, David J Elliot, Andrew A Somogyi, et al.
Pharmacogenomics and Personalized Medicine|December 11, 2012
Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysisJanet K Coller, Julia Beardsley, James Bignold, et al.
Pharmacogenetics and Genomics|January 29, 2014
Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS studyDaniel T Barratt, Benedikte Bandak, Pål Klepstad, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 10, 2014
Pilot dose-response trial of i.v. ketamine in treatment-resistant depressionRosalyn Lai, Natalie Katalinic, Paul Glue, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 1, 2000
CT-image-based conformal brachytherapy of breast cancer. The significance of semi-3-D and 3-D treatment planningC Polgár, T Major, A Somogyi, et al.
British Journal of Clinical Pharmacology|November 19, 2011
Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjectsEloise A Gelston, Janet K Coller, Olga V Lopatko, et al.
Pharmacogenetics and Genomics|May 17, 2018
Pharmacogenomics in Papua New Guineans: unique profiles and implications for enhancing drug efficacy while improving drug safetyJoseph D Tucci, Paul P Pumuye, Nuala A Helsby, et al.
British Journal of Pharmacology|October 4, 2006
Blood-brain distribution of morphine-6-glucuronide in sheepH H Villesen, D J R Foster, R N Upton, et al.
Pageof 39